Skip to main content
ESTA
NASDAQ Industrial Applications And Services

Establishment Labs Reports Strong Q1 Results, Raises Full-Year Revenue Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$73
Mkt Cap
$2.086B
52W Low
$32.25
52W High
$83.31
52W Position info
126% above low
Off High info
12% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

ESTA has more than doubled off its 52-week low of $32.25.

Summary

Establishment Labs reported strong Q1 2026 financial results, including significant revenue growth and positive Adjusted EBITDA, leading to an upward revision of its full-year revenue guidance and a projected free cash flow positive second half.


Key Events · Earnings and Guidance · ESTA

  • Strong Q1 2026 Financial Performance

    Reported revenue of $59.9 million, a 44.7% increase from Q1 2025, with gross margin improving to 70.7% from 67.2% in the prior-year period. Loss from operations significantly reduced to $6.5 million from $16.9 million.

  • Achieved Positive Adjusted EBITDA

    Reported Adjusted EBITDA income of $1.2 million for Q1 2026, a substantial improvement from a $12.1 million loss in the year-ago period, marking the third consecutive quarter of positive Adjusted EBITDA.

  • Raised Full-Year 2026 Guidance

    Increased full-year revenue guidance to a range of $266.5 million to $268.5 million, up from the previous range of $264 million to $266 million. Guidance for the minimally invasive business was also raised to exceed $35 million.

  • Path to Free Cash Flow Positive

    The company expects to be free cash flow positive in the second half of 2026, further enhancing its financial stability.


Analysis · ESTA · Industrial Applications And Services

Establishment Labs Holdings Inc. reported robust first-quarter results, demonstrating significant operational leverage and strong growth. The company achieved a 44.7% year-over-year revenue increase and notably shifted to a positive Adjusted EBITDA of $1.2 million, marking its third consecutive quarter of positive Adjusted EBITDA. This strong performance has led management to raise its full-year 2026 revenue guidance and increase expectations for its minimally invasive business. The improved financial outlook, coupled with the recently secured $300 million credit facility on April 30, 2026, significantly enhances the company's financial flexibility and provides a clear path to becoming free cash flow positive in the second half of the year. This filing indicates a positive trajectory for the company's financial health and growth strategy.

At the time of this filing, ESTA was trading at $73.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $32.25 to $83.31. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ESTA - Latest Insights

ESTA
Aug 06, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $91.18
Real-time Price: $80.39 info
Change: -$10.79 (-12%) info
Market Cap: $2.326B info
ESTA
Aug 06, 2026, 8:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $90.82
Real-time Price: $80.39 info
Change: -$10.43 (-11%) info
Market Cap: $2.326B info
ESTA
Jun 29, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $89.99
Real-time Price: $80.39 info
Change: -$9.60 (-11%) info
Market Cap: $2.326B info
ESTA
May 08, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $71.77
Real-time Price: $80.39 info
Change: +$8.62 (+12%) info
Market Cap: $2.326B info
ESTA
Apr 30, 2026, 3:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $68.21
Real-time Price: $80.39 info
Change: +$12.18 (+18%) info
Market Cap: $2.326B info